Prediction of Radiation Doses from Therapy Using Tracer Studies with Iodine-131-Labeled Antibodies

Diane A. DeNardo; Gerald L. DeNardo; Aina Yuan; Sui Shen; Sally J. DeNardo; Daniel J. Macey; Kathleen R. Lamborn; Marc Mahe; Mark W. Groch; William D. Erwin

Research ArticleHuman Studies

Prediction of Radiation Doses from Therapy Using Tracer Studies with Iodine-131-Labeled Antibodies

Diane A. DeNardo, Gerald L. DeNardo, Aina Yuan, Sui Shen, Sally J. DeNardo, Daniel J. Macey, Kathleen R. Lamborn, Marc Mahe, Mark W. Groch and William D. Erwin

Journal of Nuclear Medicine December 1996, 37 (12) 1970-1975;

Diane A. DeNardo

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gerald L. DeNardo

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Aina Yuan

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sui Shen

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sally J. DeNardo

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Daniel J. Macey

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kathleen R. Lamborn

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Marc Mahe

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark W. Groch

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

William D. Erwin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 37, Issue 12

December 1, 1996

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Prediction of Radiation Doses from Therapy Using Tracer Studies with Iodine-131-Labeled Antibodies

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Prediction of Radiation Doses from Therapy Using Tracer Studies with Iodine-131-Labeled Antibodies

Diane A. DeNardo, Gerald L. DeNardo, Aina Yuan, Sui Shen, Sally J. DeNardo, Daniel J. Macey, Kathleen R. Lamborn, Marc Mahe, Mark W. Groch, William D. Erwin

Journal of Nuclear Medicine Dec 1996, 37 (12) 1970-1975;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Prediction of Radiation Doses from Therapy Using Tracer Studies with Iodine-131-Labeled Antibodies

Diane A. DeNardo, Gerald L. DeNardo, Aina Yuan, Sui Shen, Sally J. DeNardo, Daniel J. Macey, Kathleen R. Lamborn, Marc Mahe, Mark W. Groch, William D. Erwin

Journal of Nuclear Medicine Dec 1996, 37 (12) 1970-1975;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan
Myeloablative 131I-Tositumomab Radioimmunotherapy in Treating Non-Hodgkin's Lymphoma: Comparison of Dosimetry Based on Whole-Body Retention and Dose to Critical Organ Receiving the Highest Dose
Model-Based Versus Patient-Specific Dosimetry: Blurring the Lines
An Activity Quantification Method Based on Registration of CT and Whole-Body Scintillation Camera Images, with Application to 131I
67Cu- versus131I-Labeled Lym-1 Antibody: Comparative Pharmacokinetics and Dosimetry in Patients with Non-Hodgkin's Lymphoma

Google Scholar

Main menu

User menu

Search

Prediction of Radiation Doses from Therapy Using Tracer Studies with Iodine-131-Labeled Antibodies

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles